DISTINCT SENSITIVITY OF NEUROBLASTOMA-CELLS FOR RETINOID RECEPTOR AGONISTS - EVIDENCE FOR FUNCTIONAL RECEPTOR HETERODIMERS

Citation
A. Carpentier et al., DISTINCT SENSITIVITY OF NEUROBLASTOMA-CELLS FOR RETINOID RECEPTOR AGONISTS - EVIDENCE FOR FUNCTIONAL RECEPTOR HETERODIMERS, Oncogene, 15(15), 1997, pp. 1805-1813
Citations number
51
Categorie Soggetti
Oncology,Biology,"Cell Biology
Journal title
ISSN journal
09509232
Volume
15
Issue
15
Year of publication
1997
Pages
1805 - 1813
Database
ISI
SICI code
0950-9232(1997)15:15<1805:DSONFR>2.0.ZU;2-E
Abstract
Retinoic acid (RA) plays a major role in embryogenesis of the nervous system and has been reported to induce differentiation in neuroblastom a cell lines. To identify RA signaling pathways involved in such diffe rentiation processes, two RA-sensitive neuroblastoma cell lines (LA-N- 5 and SH-SY5Y) were extensively studied. Northern blot experiments det ermined that of the three RAR mRNAs, only RAR alpha was significantly expressed, with respectively weak or undetectable levels of RAR gamma and RAR beta. RXRs (alpha and beta) receptors were weakly expressed, W estern blotting analysis confirmed the constitutive expression of RAR alpha and absence of RAR beta and weak levels of RXR alpha. Treatment with all-trans-RA up-regulated RAR alpha and induced a drastic increas e of RAR beta (both at the RNA and protein level). To further characte rize the function of RAR alpha, RAR beta and RXR alpha in NB cells, nu clear extracts from LA-N-5 cells were analysed by EMSA studies. Three specific retarded complexes were observed which were significantly dec reased or shifted in the presence of monoclonal antibodies to RAR alph a, RAR beta and RXR alpha. RA treatment dramatically induced a DR5-bin ding RXR alpha-RAR beta heterodimer. Treatment with combinations of RA R alpha or RAR beta agonists with a RXR alpha agonist or with a RAR al pha agonist alone, induced neurite-outgrowth supporting the probabilit y that both RXR alpha-RAR alpha or RXR alpha-RAR beta heterodimers are involved in RA-mediated differentiation of NB cells. The availability of novel synthetic RA-specific receptor ligands should provide the po ssibility of tissue specific therapeutic regimes.